Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B.G. Cosio, D. Guerrero, R. Cordova, G. Peces-Barba, C. Esteban, A. de Diego, J. Gea, M. Garcia-Nuñez, E. Monsó, A. Agusti (Palma de Mallorca, Bunyola, Madrid, Galdacano, Valencia, Barcelona, Badalona, Sabadell, Spain). Interaction of relevant domains in the heterogeneity of severe COPD exacerbations: The exacerbome network. Eur Respir J 2012; 40: Suppl. 56, 3229

Member's Comments

No comment yet.

Related content which might interest you: Prediction models for exacerbations in different COPD patient populations: Results of five large databases Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Agreement of severity stages and exacerbations building the new COPD risk groups Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 The main disease-related cost drivers in COPD: impaired lung function and exacerbations Source: Eur Respir J 2003; 22: Suppl. 45, 216s Year: 2003 COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020 Year: 2021 Readmissions in COPD: The perspective of the patient Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Defining the clinical clusters of severe asthma within UBIOPRED Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015 Relationship between depression and exacerbations in COPD: a response Source: Eur Respir J 2008; 32: 1126-1127 Year: 2008 What are the differences between moderate and severe COPD exacerbation groups? Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Comparison of COPD patients with high and low symptoms from a real-world US survey Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT Source: International Congress 2014 – Markers Year: 2014 Midrange-proadrenomedullin in stable state predicts severe exacerbation of COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Genetic comparison between severe persistent asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 81s Year: 2003 MUC1-CT mediates corticosteroid responses in COPD Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Prediction models for exacerbations in patients with COPD Source: Eur Respir Rev 2017; 26: 160061 Year: 2017 Comparison of different activity measures in patients with severe COPD Source: Eur Respir J 2006; 28: Suppl. 50, 68s Year: 2006